GR3021500T3 - Potentiating cell-mediated immunity utilizing polyamine derivatives - Google Patents
Potentiating cell-mediated immunity utilizing polyamine derivativesInfo
- Publication number
- GR3021500T3 GR3021500T3 GR960402869T GR960402869T GR3021500T3 GR 3021500 T3 GR3021500 T3 GR 3021500T3 GR 960402869 T GR960402869 T GR 960402869T GR 960402869 T GR960402869 T GR 960402869T GR 3021500 T3 GR3021500 T3 GR 3021500T3
- Authority
- GR
- Greece
- Prior art keywords
- mediated immunity
- polyamine derivatives
- potentiating cell
- potentiating
- cell
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35573689A | 1989-05-23 | 1989-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3021500T3 true GR3021500T3 (en) | 1997-01-31 |
Family
ID=23398633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR960402869T GR3021500T3 (en) | 1989-05-23 | 1996-10-30 | Potentiating cell-mediated immunity utilizing polyamine derivatives |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0399519B1 (el) |
| JP (1) | JP2835773B2 (el) |
| KR (1) | KR900017577A (el) |
| AT (1) | ATE141048T1 (el) |
| AU (1) | AU628174B2 (el) |
| DE (1) | DE69028006T2 (el) |
| DK (1) | DK0399519T3 (el) |
| ES (1) | ES2092481T3 (el) |
| GR (1) | GR3021500T3 (el) |
| IE (1) | IE81081B1 (el) |
| ZA (1) | ZA903804B (el) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5561136A (en) * | 1990-12-13 | 1996-10-01 | Merrell Pharmaceuticals Inc. | Method of treating cancer by conjunctive therapy with N,N'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent |
| ZA919695B (en) * | 1990-12-13 | 1992-09-30 | Merrell Dow Pharma | Method of treating cancer by conjunctive therapy with n,n'-bis(3-(ethylamino)propyl)-1,7-heptanediamine and a cytotoxic agent |
| GB9220921D0 (en) * | 1992-10-05 | 1992-11-18 | Merrell Dow Pharma | Polyamine derivatives as anticytomegaloviral agents |
| JPH09505058A (ja) * | 1993-11-15 | 1997-05-20 | ベイカー・メディカル・リサーチ・インスティテュート | 心機能不全の治療方法およびそのために有用な医薬組成物 |
| FR2724379B1 (fr) * | 1994-09-13 | 1996-11-29 | Fournier Sca Lab | Procede de fabrication de polyamines qui sont des homologues structuraux de la spermidine. |
| US5516807A (en) * | 1994-10-25 | 1996-05-14 | Warner-Lambert Company | Method for treating vascular proliferative disorders following balloon angioplasty |
| US7087648B1 (en) | 1997-10-27 | 2006-08-08 | The Regents Of The University Of California | Methods for modulating macrophage proliferation using polyamine analogs |
| US8198334B2 (en) | 1997-10-27 | 2012-06-12 | Pathologica Llc | Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
| AU2003231670B2 (en) * | 1997-10-27 | 2006-06-08 | Slil Biomedical Corporation | Methods for modulating macrophage proliferation using polyamine analogs |
| AU2001251735B2 (en) * | 2000-03-24 | 2005-09-01 | Mediquest Therapeutics, Inc. | Polyamine analogues as cytotoxic agents |
| US6919483B2 (en) * | 2003-05-23 | 2005-07-19 | Mediquest Therapeutics, Inc. | Immunomodulation with novel pharmaceutical compositions |
| CA3089388A1 (en) * | 2018-01-30 | 2019-08-08 | Sun Biopharma, Inc. | Methods for producing (6s,15s)-3,8,13,18-tetraazaicosane-6,15-diol |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5998015A (ja) * | 1982-11-27 | 1984-06-06 | Microbial Chem Res Found | 免疫賦活剤 |
| NZ212053A (en) * | 1984-05-17 | 1988-02-29 | Merrell Dow Pharma | Polyamine containing pharmaceutical compositions for treating neoplasms |
| JPS62263127A (ja) * | 1986-05-06 | 1987-11-16 | メレルダウフア−マス−テイカルズ インコ−ポレ−テツド | 自己由来のｌａｋ細胞、インタ−ロイキン−２、及びオルニチンデカルボキシラ−ゼ阻害剤による腫瘍の処置 |
| NZ223340A (en) * | 1987-02-03 | 1991-03-26 | Merrell Dow Pharma | Polyamine derivatives and pharmaceutical compositions |
-
1990
- 1990-05-17 ZA ZA903804A patent/ZA903804B/xx unknown
- 1990-05-17 AU AU55171/90A patent/AU628174B2/en not_active Ceased
- 1990-05-22 IE IE184590A patent/IE81081B1/en not_active IP Right Cessation
- 1990-05-23 KR KR1019900007406A patent/KR900017577A/ko not_active Application Discontinuation
- 1990-05-23 DE DE69028006T patent/DE69028006T2/de not_active Expired - Fee Related
- 1990-05-23 JP JP2131454A patent/JP2835773B2/ja not_active Expired - Lifetime
- 1990-05-23 DK DK90109847.5T patent/DK0399519T3/da active
- 1990-05-23 AT AT90109847T patent/ATE141048T1/de not_active IP Right Cessation
- 1990-05-23 EP EP90109847A patent/EP0399519B1/en not_active Expired - Lifetime
- 1990-05-23 ES ES90109847T patent/ES2092481T3/es not_active Expired - Lifetime
-
1996
- 1996-10-30 GR GR960402869T patent/GR3021500T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0399519T3 (da) | 1996-09-02 |
| EP0399519A3 (en) | 1991-12-04 |
| JP2835773B2 (ja) | 1998-12-14 |
| EP0399519A2 (en) | 1990-11-28 |
| DE69028006T2 (de) | 1997-03-20 |
| DE69028006D1 (de) | 1996-09-12 |
| AU5517190A (en) | 1990-11-29 |
| JPH035420A (ja) | 1991-01-11 |
| ATE141048T1 (de) | 1996-08-15 |
| AU628174B2 (en) | 1992-09-10 |
| ES2092481T3 (es) | 1996-12-01 |
| KR900017577A (ko) | 1990-12-19 |
| EP0399519B1 (en) | 1996-08-07 |
| IE901845L (en) | 1990-11-23 |
| IE81081B1 (en) | 2000-02-23 |
| ZA903804B (en) | 1991-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW349946B (en) | Novel naphthyl compounds and their process for preparation and pharmaceutical compositions containing same | |
| GR3021500T3 (en) | Potentiating cell-mediated immunity utilizing polyamine derivatives | |
| HUT61300A (en) | Process for producing pyrazolepyridine derivatives and pharmaceutical compositions comprising same as active ingredient | |
| GR3021182T3 (en) | New peptide compound and a process for the preparation thereof | |
| HK1004551A1 (en) | Xanthine derivatives process for their preparation and pharmaceutical compositions | |
| NZ229347A (en) | Substituted cephalosporin derivatives; pharmaceutical compositions, preparatory processes and intermediates | |
| MY106314A (en) | New tetrazole derivatives, process for their preparation and their use | |
| AU2347088A (en) | Polyamine derivatives as antineoplastic agents | |
| PH24309A (en) | Cycloalkylamides of(8beta)-1-alkyl-6-(substituted)-ergolines and pharmaceutical formulations thereof | |
| IL85822A (en) | 7-alkanesulphonoamido-1,2,4,5-tetrahydro-3h-3-benzazepine derivatives,their preparation and pharmaceutical compositions containing them | |
| GR3003720T3 (el) | ||
| HUT53522A (en) | Process for producing pharmaceutical compositions comprising purine derivatives | |
| ES556552A0 (es) | Un procedimiento para preparar un derivado de 1,5-benzotiazepina | |
| HU906230D0 (en) | Process for the preparation of benzanilide derivatives and medical preparations containing them | |
| KR960014780B1 (en) | Dental plaque inhibitor composition and its preparation | |
| MY109729A (en) | Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same | |
| AU657423B2 (en) | Novel piperidine derivatives and process for preparation thereof | |
| GR81759B (el) | ||
| IL116557A0 (en) | Antiherpes peptidomimetic compounds their preparation and pharmaceutical compositions containing them | |
| PT99964A (pt) | Derivados de partricina processo para a sua preparacao e composicoes farmaceuticas que os contem |